JORDAN PRESTO: Open Payments
NPI 1093354219 · HOLLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 62 payments from 16 companies in 2025. Trend: 2023 $84 · 2024 $47 · 2025 $1,377
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $224 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $206 |
| ABBVIE INC. | 15 | $197 |
| Lundbeck LLC | 8 | $187 |
| AstraZeneca Pharmaceuticals LP | 3 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Organon LLC | 3 | $69 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
Products named: REXULTI, VRAYLAR, AIRSUPRA, CAPLYTA, INJECTAFER, LILETTA, NEXPLANON, BREZTRI.
Industry payments across MI — which companies pay providers there.
